Search
for
Sort by
Research 151–180 of 580
- Modern Management Approaches for Alopecia Areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Review of Promising Off-Label Use of Deucravacitinib